Article Details
Retrieved on: 2018-03-17 21:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>TEL AVIV, Israel, March 18, 2018 /PRNewswire/ -- MedyMatch Technology, a company focused on assisting physicians provide accurate patient assessment through <b>artificial intelligence</b>-based insights, (which recently received FDA Breakthrough Designation for its intracranial hemorrhage (ICH) ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here